The company is an innovative biopharmaceutical enterprise mainly engaged in R&D, production and sales of recombinant protein drugs and microecological preparations. It focuses on treatment fields such as antiviral, tumor and immunity, hematology, digestion, degenerative diseases, etc., building cutting-edge biotechnology platforms for novel proteins, novel antibodies, nucleic acid drugs, etc., adhering to the “innovation+internationalization” two-wheel drive platform-based development model, while exploring the wide application of biotechnology in the field of health, actively cultivating and incubating new industries. It has now invested in cutting-edge fields such as animal vaccines and synthetic biology, and is committed to becoming a leader in biopharmaceutical services Patients around the world. The company is an innovative international biopharmaceutical enterprise mainly engaged in the integration of R&D, production and sales of recombinant protein drugs and microecological preparations, focusing on treatment fields such as antiviral, tumor and immunity, blood, digestion, and degenerative diseases. The main products and services are R&D, production and sales of biological products, chemicals, APIs, and traditional Chinese medicines (excluding hazardous chemicals). The company was recognized as “Shandong Provincial Enterprise Technology Center” in 2017, “Jinan Protein Pharmaceutical Engineering Laboratory” in 2018, and “Guangdong Genetic Engineering Recombinant Protein Drug Engineering Technology Center”, “Shandong Protein Drug Engineering Laboratory” and “Shenzhen Postdoctoral Innovation Practice Base” in 2020. It was awarded the honorary title of “Jinan Green Factory” by the Jinan Municipal Bureau of Industry and Information Technology in Shandong Province.
No Data